# A Study to Compare the Actions in the Body of Healthy Subjects of Three Modified Release Formulations of YM178 Under Fasted and Fed Conditions With One Immediate Release Formulation of YM178 Under Fasted Conditions

> **NCT01646294** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Europe B.V.** · enrollment: 34 (actual)

## Conditions studied

- Pharmacokinetics of YM178
- Healthy Subjects

## Interventions

- **DRUG:** YM178 modified release (OCAS)
- **DRUG:** YM178 immediate release (IR)

## Key facts

- **NCT ID:** NCT01646294
- **Lead sponsor:** Astellas Pharma Europe B.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2013-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01646294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01646294, "A Study to Compare the Actions in the Body of Healthy Subjects of Three Modified Release Formulations of YM178 Under Fasted and Fed Conditions With One Immediate Release Formulation of YM178 Under Fasted Conditions". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01646294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*